🇺🇸 FDA
Patent

US 11752197

Macrophage stimulating 1 receptor (MST1R) variants and uses thereof

granted A61KA61K31/12A61K31/4355

Quick answer

US patent 11752197 (Macrophage stimulating 1 receptor (MST1R) variants and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/12, A61K31/4355, A61K31/4741, A61K31/7088